ENPEP and early-onset autosomal dominant Alzheimer disease: In the current study, we determined the efficacy of APα to promote the survival of newly generated neural cells while simultaneously reducing Alzheimer's disease (AD) pathology in the same mouse model with different APα treatment regimens.